In plain language
In 60 mostly young cardiac catheterization patients, higher body mass index (BMI) was linked to higher patient dose, and senior cardiologists had the highest effective doses among the fluoroscopy team, based on thermoluminescent dosimeter (TLD) measurements; no dose figures were reported in the abstract.
At a glance
- Type of study
- Original research, Dosimetry measurement study
- Who was studied
- Interventional cardiologists, Mixed lab staff, Patients
- Size
- n = 60 patients
- Summary based on
- the abstract
What it found
Patients with higher BMI received higher radiation doses during interventional and diagnostic cardiac procedures.
Senior cardiologists received the highest effective doses among participating staff.
Staff doses were measured with TLDs placed both under and above lead aprons.
Patients spanned ages 1 month to 32 years and were grouped into five BMI categories.
Key figures: 60 patients; BMI <10 to 25-30 kg/m2
Limits to keep in mind
Small single-series dosimetry study of 60 largely young patients; the abstract gives no numerical doses, staff numbers, country, or statistical analysis, so effect sizes cannot be judged.
Related research summaries
- Radiation protection practices in diagnostic and interventional cardiology: Position paper from Portuguese Association of Interventional Cardiology (2025, Guideline or consensus statement)
- Radiation Safety in Chronic Total Occlusion Percutaneous Coronary Intervention (2025, Narrative review)
- NCRP Commentary 26 - Guidance on Radiation Dose Limits for Lens of Eye (2016, Guideline or consensus statement)
- Radiation safety program for the cardiac catheterization laboratory (2011, Guideline or consensus statement)
- Two Central Nervous System Tumors in One Catheter Lab: Time to Rethink Radiation Protection (2026, Retrospective cohort study)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.